Tian'an Pharmaceutical Co (TNPH) Financial Statements
Tian'an Pharmaceutical Co Financial Overview
Tian'an Pharmaceutical Co's market cap is currently $24.00M. The company's EPS TTM is $0.00; its P/E ratio is -1961.10; Tian'an Pharmaceutical Co has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 142.84K | $ 7.50K | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 67.59K | $ 7.50K | $ 0.00 |
| Operating Income | $ -4.64K | $ -18.41K | $ -10.65K | $ -33.45K | $ -31.40K |
| EBITDA | $ -4.64K | $ -1.41K | $ -10.15K | $ 208.04K | $ -31.40K |
| Net Income | $ -4.64K | $ -1.41K | $ -16.03K | $ -20.45K | $ -31.39K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ -37.00 | $ 143.00 | $ 2.58K | $ 2.15K | $ 107.18K |
| Total Assets | $ 6.83K | $ 5.71K | $ 359.59K | $ 7.42K | $ 396.43K |
| Total Debt | $ 71.58K | $ 61.86K | $ 56.95K | $ 182.00K | $ 175.57K |
| Net Debt | $ 71.62K | $ 61.72K | $ 54.37K | $ 179.84K | $ 68.39K |
| Total Liabilities | $ 107.08K | $ 91.36K | $ 425.00K | $ 208.49K | $ 522.35K |
| Stockholders' Equity | $ -100.25K | $ -85.65K | $ -70.50K | $ -201.07K | $ -139.35K |
| Cash Flow | |||||
| Free Cash Flow | $ -8.70K | $ -3.18K | $ -13.02K | $ -14.04K | $ -26.22K |
| Operating Cash Flow | $ -8.70K | $ -3.18K | $ -13.02K | $ -14.04K | $ -26.22K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 8.65K | $ 3.01K | $ 13.45K | $ 6.43K | $ 20.98K |
Currency in USD